David Frankenfield

Operating Partner - Health at Braxton Capital Pte Ltd · United States

Invests in AI

AI is one of the sectors on David Frankenfield's investor profile, next to Healthcare & Biotech and Digital Health & HealthTech, at early-stage venture and late-stage venture. No deals are on record yet, so this page lists the startup credits a company at these stages can claim.

Email Investor

Email Investor

Credits to line up before an early-stage round

David Frankenfield backs companies at early-stage venture and late-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Digital Health & HealthTech
Rounds
Early-stage venture, Late-stage venture
Profile
Venture investor
Deals on record
None yet
Based in
United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does David Frankenfield invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on David Frankenfield's investor profile, together with Healthcare & Biotech and Digital Health & HealthTech. The stages on record are early-stage venture and late-stage venture.
What credits can a startup claim before pitching David Frankenfield?
For a company raising an early-stage round, AI Perks lists credits such as Vercel (up to $850,000), Alibaba Cloud (up to Up to $120,000 + 2B Model Studio tokens), Oracle (up to $10,000) and Appwrite (up to $20,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor